Introduction {#Sec1}
============

Welding fume exposure occurs in many industrial fields. It is estimated that approximately 800,000 full-time welders were exposed to welding fumes during welding. If welders working at part-time jobs are included, many more welders may be exposed worldwide (Sferlazza and Beckett [@CR28]). Welding fumes are created when metal is united with pressure and heat. During this process, many injurious factors are generated, including welding fumes, ozone, and gases, such as nitric oxide and steam vapor, as well as ionizing and non-ionizing radiation (Harris [@CR2]; Burgess [@CR8]). In particular, welding fume components, such as Fe, Cr, and Ni, can cause pulmonary disease (Antonini et al. [@CR4]).

Many studies have been conducted regarding the injurious factors generated during the welding process. These studies have focused on the toxicological operation of the lungs during welding fume exposure. Furthermore, the correlation between the injurious components of welding fumes including pulmonary diseases, such as siderosis, immunosuppression, and lung cancer, has also been studied (Antonini et al. [@CR3]). Acute exposure to welding fumes induces metal fume fever (Mueller and Seger [@CR17]) and reversible respiratory symptoms (El-Zein et al. [@CR10]; Wolf et al. [@CR34]). Moreover, welding fumes induce asthma in welders, and there is an increase in the inflammatory transition of the lungs, such as in chronic bronchitis (El-Zein et al. [@CR10]). These studies show that exposure to a high concentration of welding fumes over the long term induces pulmonary diseases. Yu et al. established that a stainless steel welding fume generation system produced pneumotoxic effects, and lung fibrosis was induced by exposure to chronic and high concentrations of welding fumes in Sprague--Dawley rats (Yu et al. [@CR36], [@CR37], [@CR38], [@CR39]). Although the toxicological effects of welding fumes on lung injury have been studied using animal models, information about the molecular and genetic events that cause lung injury or trigger the inflammatory response to prevent injury is lacking.

Recently, microarray analysis has been used in toxicology to interpret the toxicological effects at the transcriptional level and to identify genetic biomarkers in specific target cells or tissues (Young [@CR35], Chung et al. [@CR9]; Oda et al. [@CR19]; Powell et al. [@CR23]). Moreover, phenotype-anchored gene expression profiles suggest that various toxicological endpoints or diseases can be classified or predicted by gene expression patterns (Alizadeh et al. [@CR1]; Bittner et al. [@CR6]). Gene expression analysis has been used to investigate peripheral blood mononuclear cells in which pneumoconiosis symptoms were caused in a rat model after a 30-day exposure to welding fumes (Rim et al. [@CR26]). In a previous study, we also investigated gene expression profiling in lung injury in Sprague--Dawley rats after welding fume exposure and recovery (Oh et al. [@CR20]). Although gene expression profiling has been performed in animal models, there are differences in transcriptomic regulation between humans and animals.

Thus, in this study, the cynomolgus monkey model, the genome of which is highly homologous to the human genome, was used to investigate gene expression profiling of lung injury following welding fume exposure. Gene expression profiling using a monkey model may reduce interspecies variances between an animal model and humans and help to address the toxicity of welding fume exposure in the human lung. We also compared gene expression profiles between the rat and the monkey to analyze the genetic level correlation and assess the reliability of expression patterns in the monkey model, because we used a limited number of monkeys in the study. This is the first comprehensive report on gene expression in the lungs of monkeys after welding fume exposure and recovery. This study provided molecular insights in the lung tissues when welding fumes were repeatedly infiltrated.

Materials and methods {#Sec2}
=====================

Generation of MMA-SS welding fumes {#Sec3}
----------------------------------

The welding fumes were generated using an automatic robotic arm as a holding support for the welding rod (KST 308, 2.6 mm× 300 mm, Korea Welding Electrode Co. Ltd, Seoul, Korea) as previously described (Sung et al. [@CR31]; Park et al. [@CR22]). When the robotic arm approached the base stainless steel plate (SUS 304, 2.5 cm thick) in a zigzag motion, an arc was produced and the rod was consumed, generating welding fumes. The fumes were then moved into exposure chambers (whole-body type, each 1.5 m^3^, Dusturbo, Seoul, Korea) that were rectangular in shape and made of metal with a Plexiglas window. Each chamber accommodated two monkey cages, and the total volume occupied by the two monkeys in a chamber was estimated as 1.3%. The chambers were equipped with HEPA filters to provide purified air to the exposure chambers. The welding fumes in the chamber were sampled using a personal sampler (MSA 484107, Pittsburgh, PA) at a flow rate of 2 l/min. The metal composition of the welding fume particulates captured on membrane filters (pore size 0.8 μm, 37 mm diameter, Millipore AAWP 03700, Bedford MA, USA) was analyzed for metal composition with an inductively coupled plasma analyzer (Thermojeralash, IRIS, Houston, TX, USA), using the NIOSH method 7300 ([@CR18]). Nitrous fumes, O~3~, and NO~2~ were all measured using Drager tubes (catalog numbers 6733181, CH 31001, and CH 30001, respectively) and sampled by stroking a gas detector pump (6400000, Drager, Lubeck, Germany), according to the manufacturer's directions 1 h after the welding fume exposure began. An Anderson sampler (AN-200, Shibata, Tokyo, Japan) was used to measure the mass media aerodynamic diameters of the welding fumes. The flow rate was 28.3 l/min, and the samples were collected for 5 min.

Exposure to welding fumes {#Sec4}
-------------------------

Monkeys were exposed to the welding fumes as described previously (Sung et al. [@CR31]; Park et al. ([@CR22]). Six 63 ± 5-month-old, male cynomolgus monkeys (3.7 ± 0.7 kg; *Macaca fascicularis*) were purchased from the Yunnan National Laboratory Primate Center (China) and acclimated for a 3-month period. The sequestered animal room was maintained at a temperature of 23 ± 3°C and a relative humidity of 55 ± 10%, with air ventilation 10--20 times/h, a light intensity of 150--300 lux, and a 12/12-h light/dark cycle (8 am to 8 pm). Throughout the study, the monkeys were individually housed in stainless steel wire cages (660 W × 800 l × 850 H mm) and fed a standard monkey diet (Oriental Yeast Co., Tokyo, Japan). No dietary supplement, such as fruit, was provided. Ultraviolet-irradiated and filtered municipal tap water was provided to the animals ad libitum. All animals were cared for in accordance with the principles outlined in the "Guide for the Care and Use of Laboratory Animals," an NRC publication (ILAR [@CR41]). The monkeys were randomly assigned to three groups (unexposed, *n* = 2; low dose, *n* = 2; and high dose, *n* = 2), using the Path/Tox System (Version 4.2.2, Xybion Medical Systems Corporation, Cedar Knolls, NJ, USA), and exposed to welding fumes for 2 h/day, 5 days/week (1:30 pm to 3:30 pm) in the exposure chambers. Before initiating the inhalation exposure, the monkeys were taken out of their normal cages and housed in individual wire cages (450 W × 600 l × 460 H mm) that were specially designed for the inhalation experiment. In total, four monkeys, two in each chamber, were concurrently exposed during each 2-h exposure period. One monkey was used in each test group and recovery group. The control animals were not placed in the inhalation chamber; they remained in the cage during the 2-h exposure period. Food and water were not provided during the 2-h exposure, and the monkeys were taken out of the chambers at the end of the 2-h exposure. The time-weighted average (TWA) concentrations for the exposure doses were 31.4 ± 2.8 mg/m^3^ (T1) and 62.5 ± 2.7 mg/m^3^ (T2) total suspended particulates per 2 h. The target concentrations were achieved by varying the flow rates, by adjusting the dampers. Necropsies were performed after the 229 days of exposure and after the 153-day recovery period.

Histopathology {#Sec5}
--------------

Lung samples collected from exposed, recovered, and control monkey were fixed in 10% neutral buffered formalin and embedded in paraffin. Sections (4 μm) were cut using a microtome (RM2165; Leica, Wetzlar, Germany), stained with hematoxylin and eosin, and examined under a light microscope (E400; Nikon, Tokyo, Japan).

Isolation of RNA {#Sec6}
----------------

A portion of the lung samples was homogenized in Trizol reagent (Invitrogen, Carlsbad, CA, USA), and the isolated total RNA was repurified using an RNeasy mini kit (Qiagen, Valencia, CA, USA), according to the manufacturer's protocol. Total RNA was quantified using a NanoDrop spectrophotometer (NanoDrop Technologies, Montchanin, DE, USA), and the quality of RNA was evaluated using a 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA, USA) for DNA chip experiments.

Microarray analysis {#Sec7}
-------------------

The Affymetrix GeneChip^®^ Human Genome U133 Plus 2.0 array was used for the microarray analysis. Sample labeling, microarray hybridization, washing, and scanning were performed according to the manufacturer's protocol (Affymetrix, Santa Clara, CA, USA). Microarray experiments for each exposure and recovery group were duplicated and, in total, twelve arrays were used. The preprocessing procedure for the cell intensity files (CEL) and the following microarray analyses were performed using GenPlex software (Istech Inc., Goyang, Korea). Data were normalized using global scale normalization. The differentially expressed genes in the each dose group of 229-day welding fume exposure group and the 153-day recovery group were selected based on the fold change and results from the Student's *t*-test (over 2-fold and *P* \< 0.01), compared with the corresponding controls. Hierarchical clustering was also performed with the centered Pearson's correlation, using these selected genes, based on the complete linkage and distance matrix. Differentially expressed genes in the 229-day welding fume exposure group and the 153-day recovery group were imported into Ingenuity Pathways Analysis (IPA; Ingenuity Systems, Redwood, CA, USA), and the biological functions and toxicology were analyzed. Genes commonly deregulated during welding fume exposure between the monkeys and the rats were analyzed using microarray data for the 229-day welding fume exposure group of monkeys and those for the 30-day welding fume exposure group of rats, previously reported by Oh et al. ([@CR20]). In rat model for welding fume exposure, rats for T1 and T2 dose group were exposed to 51.4 ± 2.89 mg/m^3^ and 84.63 ± 2.87 mg/m^3^, respectively, for 2 h per day for up to 30 days (Oh et al. [@CR20]). Lower cutoff threshold (over 1.3-fold and *P* \< 0.01) for selecting the differentially expressed genes was performed to compare deregulated genes between two species exposed to welding fumes. Based on fold change and statistical significance, 1,342 and 4,881 differentially expressed genes were selected in the monkey and rat exposure groups, respectively. Among the 1,342 differentially expressed genes in monkeys, 534 genes with a gene symbol were selected to compare with those of the rat model. The selected genes were annotated based on NetAffx (<http://www.Affymetrix.com>).

Quantitative real-time RT-PCR {#Sec8}
-----------------------------

Gene transcripts were detected and quantified using SYBR Green (QuantiTect SYBR Green PCR Master Mix; Qiagen), according to the manufacturer's instructions, on a Rotor-Gene 6000 real-time rotary analyzer (Corbett Research, Sydney, Australia). Primers were designed using the Primer3 software (<http://frodo.wi.mit.edu/>); the primer sequences are presented in Supplemental Table 1. A melting curve analysis was performed on all amplified products to ensure the specificity and integrity of the PCR products. The *Gapdh* level was used as an internal control, and fold changes were calculated according to the 2^−ΔΔCT^ method (Livak and Schmittgen [@CR15]).

Results {#Sec9}
=======

Exposure to welding fumes and histopathology {#Sec10}
--------------------------------------------

To induce lung damage caused by welding fumes, monkeys were exposed to welding fumes at dose levels of 31.4 ± 2.8 mg/m^3^ (T1 dose) and 62.5 ± 2.7 mg/m^3^ (T2 dose) for 229 days and allowed to recover for 153 days. After the recovery period, serum biochemical and pathological examinations were performed. Serum biochemistry showed that no significant change was noticed (data not shown) in lymphocytes or neutrophils during the welding fume exposure. Histopathology showed that significant lung damage, such as pulmonary fibrosis, was not observed in either the 229-day exposure group or the 153-day recovery group. However, the lung tissues were infiltrated with welding fumes in both the T1 and T2 dose groups (Fig. [1](#Fig1){ref-type="fig"}). A similar severity of infiltration was interestingly observed in the 153-day recovery group (data not shown), even though after long-term recovery period (153-day).Fig. 1Light micrographs of monkey lungs after 229 days of welding fume exposure **a** control (×100), **b** T2 dose (62.5 ± 2.7 mg/m^3^, ×100), **c** Control (×400), **d** T2 dose (62.5 ± 2.7 mg/m^3^, ×400)

Differentially expressed genes in the monkey lungs of the welding fume-exposed and recovery groups {#Sec11}
--------------------------------------------------------------------------------------------------

For the microarray analysis, differentially expressed genes were selected from the monkey lung tissues in the welding fume exposure and recovery groups. In the exposure and recovery group, 669 (T1 dose, 365; T2 dose, 370) and 489 (T1 dose, 309; T2 dose, 239) genes were up- or down-regulated, respectively. Hierarchical clustering was performed; the results showed that samples were clustered in each dose group, many genes were commonly deregulated in both dose groups, and several genes were clustered specifically to each dose group (Fig. [2](#Fig2){ref-type="fig"}). The top 20 highly deregulated genes from the exposure group are shown in Table [1](#Tab1){ref-type="table"}. Genes involved in signaling pathways (*DGKB*, *PIAS2*, *AXIN2*), metal ion binding (*TRIM2*), DNA binding (*HIST1*, *H2BC*), and metabolism (*CHIT1*) were up-regulated in the exposure group, although most genes were not functionally annotated. In contrast, genes involved in transport (*ABCA13*, *STEAP2*, *KCNH2*, *KCNV1*), transcription (*236231_at*, *ZNF738*, *HEY2*), cell adhesion (*ACTN2*), rRNA processing (*ADAT2*), and protein binding (*SLITRK6*) were down-regulated in the exposure group.Fig. 2Hierarchical clustering of differentially expressed genes in monkey lungs from the welding fume exposure **a** and recovery **b** groupsTable 1Differentially expressed genes in monkey lungs from welding fume exposure groupGene_symbol\
/probe IDGene_titleRefSeq IDFold change (Log 2)Exp_T1Exp_T2Up-regulated genes in the exposure group* XIST*X (inactive)-specific transcriptNR_0015643.288.43* TMED6*Transmembrane emp24 protein transport domain containing 6NM_1446763.655.10 *SFRS4*Splicing factor, arginine/serine-rich 4NM_0056262.285.00 *1556192_x\_at*Full-length insert cDNA clone YR55D08--4.174.58 *242830_at*Unknown--2.494.58 *DGKB*Diacylglycerol kinase, beta 90 kDaNM_0040802.364.52 *TRIM2*Tripartite motif-containing 2NM_0152710.384.48 *EML5* Echinoderm microtubule-associated protein like 5NM_1833873.904.35 *244388_at*Transcribed locus--3.244.06 *C5orf28*Chromosome 5 open reading frame 28NM_0224834.744.05 *1564299_at*CDNA FLJ33307 fis, clone BNGH42004076--2.914.01 *1566836_at*CDNA clone IMAGE:5302735--3.533.89 *HIST1H2BC*Histone cluster 1, H2bcNM_0035264.083.80 *LOC339260*Hypothetical protein LOC339260--1.583.65 *NHSL1*NHS-like 1XM_4968262.753.63 *C6orf201*Chromosome 6 open reading frame 201NM_0010854013.253.61 *PIAS2*Protein inhibitor of activated STAT, 2NM_0046711.173.58 *AXIN2*Axin 2 (conductin, axil)NM_0046554.033.49 *CHIT1*Chitinase 1 (chitotriosidase)NM_0034652.923.32 *233010_at*CDNA FLJ14313 fis, clone PLACE3000341--3.673.30Down-regulated genes in the exposure group *OVOS2*Ovostatin 2NM_001080502−6.04−5.85 *ABCA13*ATP-binding cassette, sub-family A (ABC1), member 13NM_152701−3.64−5.77 *236945_at*Unknown--−1.89−5.68 *GPATCH2*G-patch domain containing 2NM_018040−0.20−5.04 *C20orf19*Chromosome 20 open reading frame 19NM_018474−0.30−4.99 *242818_x\_at*Transcribed locus--−0.66−4.95 *TMEFF2*Transmembrane protein with EGF-like and two follistatin-like domains 2NM_016192−1.05−4.91 *KLKB1*Kallikrein B, plasma (Fletcher factor) 1NM_000892−0.32−4.30 *ACTN2*Actinin, alpha 2NM_001103−2.90−4.03 *236231_at*Unknown--−2.14−4.01 *1569772_x\_at*CDNA clone IMAGE:4824424--−3.11−3.98 *ADAT2*Adenosine deaminase, tRNA-specific 2, TAD2 homolog (*S. cerevisiae*)NM_182503−2.37−3.83 *243548_x\_at*Transcribed locus--−1.72−3.75 *ZNF738*Zinc finger protein 738XR_015756−2.76−3.72 *SLITRK6*SLIT and NTRK-like family, member 6NM_032229−1.83−3.69 *HEY2*Hairy/enhancer-of-split related with YRPW motif 2NM_012259−2.65−3.66 *STEAP2*Six transmembrane epithelial antigen of the prostate 2NM_001040665−0.74−3.64 *TEX12*Testis expressed 12NM_031275−2.40−3.57 *KCNH2*Potassium voltage-gated channel, subfamily H (eag-related), member 2NM_000238−1.92−3.52 *KCNV1*Potassium channel, subfamily V, member 1NM_014379−2.57−3.48Fold change was calculated with relative average value of 2 arrays in each group comparing to corresponding controls and values were represented with log 2

In the recovery group, genes involved in tRNA aminoacylation (*IGL@, TARS*), antigen presentation or immune response (*HLA-DPB1, IGHM, GAGE12F*), cell differentiation or development (*THOC5, FNDC3A, DOCK7*), metabolism (*CHIT1, CPT1A*), and apoptosis (*240890_at*, *JAK2*) were up-regulated, whereas genes involved in heat shock protein binding (*DNAJC6*, *NTRK2*, *DNAJC10*), signal transduction (*RGS4*), proteolysis (*DPP10*), antigen presentation (*HLA-DPA1*), cell cycle arrest (*GAS2L3*), transcription (*ZNF483*), and development (*RICTOR*) were down-regulated (Table [2](#Tab2){ref-type="table"}).Table 2Differentially expressed genes in monkey lungs from welding fume recovery groupGene_symbol/probe IDGene_titleRefSeq IDFold change (Log 2)Rec_T1Rec_T2Up-regulated genes in the recovery group *IGL@*Immunoglobulin lambda locus--4.634.92 *1557452_at*Full-length insert cDNA clone ZC19A03--5.154.64 *HLA-DPB1*Major histocompatibility complex, class II, DP beta 1NM_0021214.534.60 *THOC5*THO complex 5NM_0010028771.594.12 *IGHM*Immunoglobulin heavy constant mu--2.663.94 *C6orf12*Chromosome 6 open reading frame 12XM_0011329064.183.88 *FNDC3A*Fibronectin type III domain containing 3ANM_0010796733.653.81 *1561906_at*Homo sapiens, clone IMAGE:3626122--3.933.81 *MRPL44*Mitochondrial ribosomal protein L44NM_0229151.993.75 *CHIT1*Chitinase 1 (chitotriosidase)NM_0034652.453.73 *DOCK7*Dedicator of cytokinesis 7NM_0334072.793.73 *HOXA9*Homeobox A9NM_1527391.553.70 *240890_at*CDNA clone IMAGE:5216666--2.563.65 *CPT1A*Carnitine palmitoyltransferase 1A (liver)NM_0010318472.933.63 *TARS*Threonyl-tRNA synthetaseNM_1522954.093.56 *1569727_at*Homo sapiens, similar to hypothetical gene LOC130797--3.123.51 *GAGE12F*G antigen 6NM_0010984053.573.42 *LOC731851*Hypothetical protein LOC731851XM_0011310413.693.37 *JAK2*Janus kinase 2 (a protein tyrosine kinase)NM_0049723.403.35 *C18orf17*Chromosome 18 open reading frame 17NM_1532111.273.33Down-regulated genes in the recovery group *RGS4*Regulator of G-protein signaling 4NM_001102445−3.25−5.20 *DPP10*Dipeptidyl-peptidase 10NM_001004360−1.42−4.64 *DNAJC6*DnaJ (Hsp40) homolog, subfamily C, member 6NM_014787−0.67−4.61 *NTRK2*Neurotrophic tyrosine kinase, receptor, type 2NM_001007097−0.85−4.32 *DNAJC10*DnaJ (Hsp40) homolog, subfamily C, member 10NM_018981−3.90−4.03 *HLA-DPA1*Major histocompatibility complex, class II, DP alpha 1NM_033554−1.64−3.87 *C11orf54*Chromosome 11 open reading frame 54NM_0140390.08−3.85 *GAS2L3*Growth arrest-specific 2 like 3NM_174942−2.55−3.84 *1560395_at*Homo sapiens, clone IMAGE:4293443, mRNA--−2.39−3.81 *FAM55C*Family with sequence similarity 55, member CNM_1450370.27−3.62 *229318_at*CDNA clone IMAGE:4814437--−2.92−3.44 *SPATA22*Spermatogenesis-associated 22NM_032598−2.50−3.35 *243302_at*Transcribed locus--−3.53−3.33 *1563397_at*EST from clone 114659, full insert--−1.86−3.33 *ZNF483*Zinc finger protein 483NM_001007169−1.42−3.31 *RICTOR*Rapamycin-insensitive companion of mTORNM_152756−3.59−3.29 *244282_at*Transcribed locus--−1.25−3.24 *234650_at*CDNA: FLJ21254 fis, clone COL01317--−2.57−3.23 *240594_at*Transcribed locus--−3.30−3.21 *CYP26B1*Cytochrome P450, family 26, subfamily B, polypeptide 1NM_019885−3.06−3.19Fold change was calculated with relative average value of two arrays in each group comparing to corresponding controls, and values were represented with log 2

Functional classification of differentially expressed genes in the welding fume exposure and recovery groups {#Sec12}
------------------------------------------------------------------------------------------------------------

The molecular mechanisms of these selected 669 and 489 genes from the exposure and recovery groups, respectively, were analyzed using IPA. As shown in Table [3](#Tab3){ref-type="table"}, the results confirmed changes in the expression of genes in the exposure group involved in immunological disease, genetic disorders, cancer, organism injury and abnormalities, and inflammatory diseases. In the recovery group, genes involved in cancer, immunological diseases, and inflammatory diseases ranked high. Among these categories, highly regulated genes related to immunological and inflammatory disease were represented in Table [4](#Tab4){ref-type="table"}. As shown in Table [4](#Tab4){ref-type="table"}, *PPID*, *CFLAR*, *CPT1A*, and *INSR* for up-regulated genes and *KLKB1*, *ATM*, *RAG1*, *UBASH3A*, *IGKC*, and *PTPN22* for down-regulated genes were consistently regulated in both exposure and recovery group.Table 3Functional classification of differentially expressed genes in the welding fume exposure or recovery groupExposureRecoveryFunctions*P*-valueNo. of genesFunctions*P*-valueNo. of genesDisease and disorder Immunological disease1.24E-05--1.32E-0258Cancer1.55E-05--2.06E-02109 Genetic disorder2.19E-05--1.48E-02152Immunological disease3.40E-05--2.06E-0241 Cancer5.55E-05--1.41E-02148Inflammatory disease2.52E-04--2.06E-0245 Organismal injury and abnormalities5.65E-05--1.35E-0227Renal and urological disease2.62E-04--2.06E-0210 Inflammatory disease1.06E-04--1.48E-0259Reproductive system disease3.27E-04--2.06E-0245Molecular and cellular functions Cellular growth and proliferation3.82E-08--1.35E-02129Cellular growth and proliferation1.84E-06--2.06E-0293 Cellular development1.20E-06--1.35E-02105Cell cycle7.30E-06--2.06E-0238 Post-translational modification8.86E-06--1.38E-0243Cell death1.55E-05--2.06E-0274 Cellular function and maintenance1.16E-05--1.40E-0222Cell morphology2.74E-05--2.06E-0258 Cell cycle2.22E-05--1.49E-0252Cellular development1.56E-04--2.06E-0267Top functional categories for differentially expressed genes are presented for the exposure and recovery groups. *P*-values were calculated by comparing the number of molecules of interest relative to the total number of occurrences of these molecules in all functional annotations stored in the Ingenuity Pathways knowledge base (Fisher's exact test with *P*-value adjusted using the Benjamin--Hochberg multiple testing correction)Table 4Top-regulated genes related to inflammation in monkey lungsGene_symbolGene_titleRefSeq IDFold change (Log 2)ExpRecT1T2T1T2Up-regulated genes *PPID*Cyclophilin-40NM_0050380.592.62−0.39−1.45* INSR*Insulin receptorNM_0002081.902.55−1.22−0.94 *CPT1A*Carnitine palmitoyltransferase 1A (liver)NM_0010318471.672.172.933.63 *ALAS2*Aminolevulinate, delta-, synthase 2NM_0000320.531.63−0.84−0.26 *CFLAR*I-FLICE isoform 5NM_0011271832.791.461.951.18 *CDK2*Cyclin-dependent kinase 2NM_0017981.051.43−1.17−0.49 *CPT1A*Carnitine palmitoyltransferase 1A (liver)NM_0010318470.831.390.640.74 *F2RL1*Coagulation factor II (thrombin) receptor-like 1NM_0052420.261.18−0.40−0.06 *PDE4D*Phosphodiesterase 4D, cAMP-specificNM_001104631−0.031.00−0.50−0.22 *INSR*Insulin receptorNM_0002081.140.571.040.97Down-regulated genes *KLKB1*Kallikrein B, plasma (Fletcher factor) 1NM_000892−0.32−4.300.08−0.57 *ATM*Ataxia telangiectasia mutatedNM_000051−1.58−3.24−0.73−0.53 *RAG1*Recombination activating gene 1NM_000448−0.62−3.20−2.17−2.51 *UBASH3A*Ubiquitin associated and SH3 domain containing, ANM_001001895−1.05−3.191.04−0.45 *IGKC*Immunoglobulin kappa constantXM_0017139380.22−3.13−1.44−1.48 *MAPK13*Mitogen-activated protein kinase 13NM_002754−1.62−2.971.091.49 *PTPN22*Protein tyrosine phosphatase, non-receptor type 22NM_012411−0.32−2.93−1.37−0.39 *MED7*Mediator complex subunit 7NM_001100816−1.52−2.641.261.11 *IGL@*Immunoglobulin lambda locus--2.88−2.370.890.57 *IFIH1*Interferon induced with helicase C domain 1NM_022168−1.48−2.37−0.58−0.26Fold change was calculated with a relative average value of two arrays in each group, compared with the corresponding controlsValues presented are log 2 transformed

When the molecular and cellular functions were analyzed, changes in the expression of genes involved in cellular growth, proliferation, and development were observed in the exposure group. Changes in the expression of genes involved in cellular growth, proliferation, and the cell cycle were also observed in the recovery group. In the analysis of toxicological functions, changes in genes involved in the G1/S transition of the cell cycle, TR/RXR activation, and hepatic fibrosis were identified in both the exposure and recovery groups. In particular, changes in genes involved in gene regulation mechanisms by peroxisome proliferation, RAR activation, and oxidative stress response mediated by Nrf2 were identified in the recovery group (Fig. [3](#Fig3){ref-type="fig"}).Fig. 3Toxicological functional analysis of differentially expressed genes in the exposure and recovery groups. Interesting categories of mode of action were selected and represented. The *dark blue* and *light blue bars* in the histogram indicate the exposure and recovery groups, respectively

Commonly deregulated genes in the lungs of monkeys and rats after welding fume exposure {#Sec13}
---------------------------------------------------------------------------------------

To compare the results from the gene expression pattern in monkey lung tissues exposed to welding fumes with those seen in rats, the expression level of 534 genes with identical gene symbols were compared as described in the \"[Materials and methods](#Sec2){ref-type="sec"}\" section. Of 534 monkey genes that showed changes in lung tissue, 76 matched changes in rats (15%). Among them, 39 were identified as up-regulated or down-regulated in both monkeys and rats (51%; Table [5](#Tab5){ref-type="table"}). Most of these genes in common were down-regulated. The common genes included *CHI3L1*, *GM2A*, *RARRES1*, *CTSK*, *DDHD1*, and *CTSB*. Among these, six genes that ranked high as either up-regulated or down-regulated genes were selected for real-time PCR to confirm gene expression (Fig. [4](#Fig4){ref-type="fig"}). Among the up-regulated lung genes from the monkey exposure group, *CHI3L1*, *RARRES1*, *DDHD1*, and *CTSB* were all up-regulated, but *GM2A* was down-regulated in rat lungs from the welding fume exposure group. However, selected down-regulated genes such as *GRAP*, *CYP1B1*, *PTGFRN ID4*, and *NRGN* in monkey lungs from the microarray analysis were all down-regulated in both monkey and rat samples. This overall result indicated that gene expression patterns detected from the microarray experiment were almost consistent with those determined from real-time PCR, and selected genes were consistently deregulated in rat samples.Table 5Commonly deregulated genes in the monkey and rat welding fume exposure groupsGene_symbolGene_titleRefSeq IDFold change (Log 2)MonkeyRatMonkeyRat^a^T1T2T1T2Up-regulated genes *CHI3L1*Chitinase 3-like 1 (cartilage glycoprotein-39)NM_001276NM_0535604.242.671.021.44 *GM2A*GM2 ganglioside activatorNM_000405NM_1723351.121.550.590.58 *RARRES1*Retinoic acid receptor responder (tazarotene induced) 1NM_002888NM_0010147901.811.531.502.10 *CTSK*Cathepsin KNM_000396NM_0315601.281.411.371.37 *DDHD1*DDHD domain containing 1NM_030637NM_0010330661.610.960.520.68 *CTSB*Cathepsin BNM_001908NM_0225971.030.770.570.86Down-regulated genes *GRAP*GRB2-related adaptor proteinNM_006613NM_001025749−2.10−2.69−0.76−0.54 *CYP1B1*NM_000104NM_012940−2.71−2.60−0.53−1.00 *CYP26B1*Cytochrome P450, family 26, subfamily B, polypeptide 1NM_019885NM_181087−1.23−1.95−0.66−0.07 *PTGFRN*Prostaglandin F2 receptor negative regulatorNM_020440NM_019243−1.63−1.91−0.59−0.55 *ID4*Inhibitor of DNA-binding 4, dominant negative helix-loop-helix proteinNM_001546NM_175582−1.35−1.65−1.82−0.97 *NRGN*Neurogranin (protein kinase C substrate, RC3)NM_006176NM_024140−2.51−1.60−0.71−0.43 *KIDINS220*Kinase D-interacting substrate of 220 kDaNM_020738NM_053795−1.08−1.55−0.38−0.49 *ANK2*Ankyrin 2, neuronalNM_001148XM_001076082−2.15−1.40−1.01−1.16 *TMPO*ThymopoietinNM_001032283NM_012887−1.31−1.30−0.39−0.27 *PTGER4*Prostaglandin E receptor 4 (subtype EP4)NM_000958NM_032076−1.42−1.27−0.44−0.47 *RHOJ*Ras homolog gene family, member JNM_020663NM_001008320−1.47−1.27−0.68−0.62 *CXCL12*Chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1)NM_000609NM_001033882−1.96−1.25−0.59−0.18 *RBP1*Retinol-binding protein 1, cellularNM_002899NM_012733−1.26−1.21−0.92−0.84 *MAMDC2*MAM domain containing 2NM_153267XM_001078660−1.59−1.19−0.84−0.48 *SPON1*Spondin 1, extracellular matrix proteinNM_006108NM_172067−1.40−1.05−0.50−0.48 *GHR*Growth hormone receptorNM_000163NM_017094−1.20−1.02−0.86−1.07 *FXYD1*FXYD domain containing ion transport regulator 1 (phospholemman)NM_005031NM_031648−1.26−0.96−0.93−0.87 *HPGD*Hydroxyprostaglandin dehydrogenase 15-(NAD)NM_000860NM_024390−1.31−0.92−1.05−1.11 *NBL1*Neuroblastoma, suppression of tumorigenicity 1NM_005380NM_031609−1.04−0.91−0.68−0.58 *WNT5A*Wingless-type MMTV integration site family, member 5ANM_003392NM_022631−1.14−0.91−0.72−1.02 *FHL1*Four and a half LIM domains 1NM_001449NM_001033926−1.11−0.87−0.58−0.56 *KCNS3*Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3NM_002252NM_031778−1.12−0.73−0.84−0.56 *SLC12A2*Solute carrier family 12 (sodium/potassium/chloride transporters), member 2NM_001046NM_031798−1.19−0.69−0.45−0.35 *ITPKB*Inositol 1,4,5-trisphosphate 3-kinase BNM_002221NM_019312−1.09−0.63−0.86−0.81 *SOX9*SRY (sex-determining region Y)-box 9 (campomelic dysplasia, autosomal sex-reversal)NM_000346XM_001081628−1.07−0.62−1.34−1.18 *G0S2*G0/G1switch 2NM_015714NM_001009632−1.03−0.60−1.02−0.77 *IGFBP6*Insulin-like growth factor binding protein 6NM_002178NM_013104−1.04−0.55−0.33−1.04 *RAB28*RAB28, member RAS oncogene familyNM_001017979NM_053978−1.12−0.51−0.38−0.36 *GBA2*Glucosidase, beta (bile acid) 2NM_020944NM_020944−1.18−0.51−0.49−0.32 *HEY1*Hairy/enhancer-of-split related with YRPW motif 1NM_001040708XM_001057389−1.05−0.46−0.50−0.63 *PDLIM3*PDZ and LIM domain 3NM_014476NM_053650−1.61−0.41−0.76−0.80 *HNRPD*Heterogeneous nuclear ribonucleoprotein D)NM_001003810NM_001082539−2.76−0.30−0.59−0.39 *RHOB*Ras homolog gene family, member BNM_004040NM_022542−1.39−0.12−0.80−0.61Fold change was calculated with a relative average value of two (monkey model) or three arrays (rat model) in each group, compared with the corresponding controls. Values presented are log 2 transformed^a^Microarray data in the rat model were used with the permission of Oh et al. ([@CR20]). Differentially expressed genes were compared as described in the \"[Materials and methods](#Sec2){ref-type="sec"}\". T1 dose means 31.4 ± 2.8 mg/m^3^ 51.4 ± 2.89 mg/m^3^ and T2 dose means 62.5 ± 2.7 and 84.63 ± 2.87 mg/m^3^ in monkey and rat models, respectivelyFig. 4Verification of top-ranked genes deregulated in monkey lung after welding fume exposure. Expression patterns of selected genes detected from the microarray experiment for monkey lung were analyzed in both the T1- and T2-dosed monkey and rat lungs by real-time PCR. **a** Six up-regulated genes, **b** Six down-regulated genes in the welding fume exposure group of monkeys. Three independent rat samples were used to confirm the gene expression levels and average fold change. The standard deviation was calculated as described in the "[Materials and methods](#Sec2){ref-type="sec"}" section

Discussion {#Sec14}
==========

In this study, we analyzed the gene expression profiles from monkey lungs injured by welding fumes for 229 days and recovered for 153 days. Welding fumes consist of particulate matter from the heavy metal materials and gases, such as ozone. The Cr(VI) and nitrous fumes can include Fe, Mn, Ni, Cr, SiO~2~, and asbestos (Antonini et al. [@CR4]; Yu et al. [@CR36]). Several studies have investigated the toxicological effects of welding fume exposure in various animal models (Hicks et al. [@CR12]; Kalliomäki et al. [@CR13], Uemitsu et al. [@CR33]). Gene expression changes should be triggered in target tissues by welding fume exposure, so microarray analysis is a useful tool for elucidating the molecular response to welding fume exposure. Rim et al. ([@CR26], [@CR27]) previously reported gene expression profiling of peripheral mononuclear cells from welding fume-exposed rats and welders. Gene expression profiling using blood samples could be useful to monitor the toxicological effects in surrogate tissues, but it is still of limited value in understanding dynamic phenomena, including lung inflammation or a response process in a target tissue. Actually, there were almost no genes consistently expressed in rat lungs (Oh et al. [@CR20]) when compared with those expressed in rat blood after welding fume exposure (Rim et al. [@CR26]). Furthermore, the use of a rodent model to predict toxic effects in humans also has limitations because of interspecies differences in toxicological responses, although central physiological functions are assumed to be almost common among mammals. For this reason, we used the monkey model to investigate gene expression profiling following welding fume exposure.

The histopathology showed that welding fumes were deposited within the lung tissues of monkeys, but there was no serious immune reaction. In a previous study, inflammation and infiltration of large numbers of immune cells into the alveoli were observed in a rat model following a 30-day welding fume exposure, and the lung almost recovered during a 30-day recovery period (Oh et al. [@CR20], [@CR21]). These histological differences in welding fume exposure between monkeys and rats may have been caused by differences in breathing volumes of the animals, the respiration rate, and the actual exposed concentration of welding fumes. In this study, exposure concentration of welding fumes was almost similar but the duration of welding fume exposure was different between monkey and rat models as follows: monkey model was exposed to 62.5 ± 2.7 mg/m^3^ (T2 dose) for 229 days, and rats were exposed to 84.63 ± 2.87 mg/m^3^ (T2 dose) for 30 days. Based on the respiratory rate between monkey (appx. 2,088 ml/min) and rat (appx. 264 ml/min) models, actual exposed concentration was estimated as previously described by Lawson ([@CR14]) and Authier et al. ([@CR5]). The actual exposed concentration was determined with 4.23 mg/kg/day and 9.68 mg/kg/day in monkey and rat models, respectively. Considering the duration of welding fume exposure, it was suggested that monkey was exposed to enough welding fumes, but welding fume accumulation in lungs has not been severe comparing to rat model. Moreover, in the monkey model, welding fumes were hardly removed from the lung after the 153-day recovery period. It seems that lung recovery or removal of welding fumes may be differently regulated in monkeys than rats. It was expected that we could understand and predict the molecular mechanism underlying welding fume exposure and the recovery process in humans using gene expression profiling in monkeys.

In the microarray analysis, the top-ranked differentially expressed genes involved in the inflammatory response were not primarily identified in the exposure and recovery groups of monkey lung, which differed from the many immune response genes identified in the rats investigated previously (Oh et al. [@CR20]). However, a biofunctional analysis of all of the differentially expressed genes showed that about 50 genes identified in the exposure and recovery groups, respectively, appeared to be primarily involved in immunological disease. Table [4](#Tab4){ref-type="table"} represented that top-regulated genes related to inflammation in exposure or recovery group. Through analysis of expression changes for a total of 50 genes related to inflammation in exposure group comparing to recovery group, we found that about 50% of genes in T2 group were consistently up- or down-regulated in both exposure and recovery groups. This result suggests that a significant inflammatory response did not occur in the lungs of welding fume-exposed monkeys but that inflammatory response was also progressed during recovery period.

Interestingly, there was a greater up-regulation of genes related to immunological disease in the recovery group than in the exposure group. The histopathology revealed that welding fumes were not removed during the 153-day recovery period, and it is thought that an inflammatory response increasingly progressed during the recovery period. Gene alterations involved in the immune response during the welding fume exposure and recovery periods were consistent with our histopathological observations. This result illustrates the utility of microarray analysis in characterizing responses to lung injury in monkeys exposed to welding fumes.

Here, we analyzed the changes in gene expression in the lungs of monkeys after welding fume exposure and recovery, but the number of individuals in each group was small. For this reason, we compared the differentially expressed genes identified in the present study with those identified in welding fume-exposed rats, which were previously reported (Oh et al. [@CR20]). Among the commonly deregulated genes in the monkey and rat after welding fume exposure, *CHI3L1*, *CTSK*, and *CTSB* were up-regulated, whereas *GRAP*, *CYP1B1*, *CYP26B1*, and *ID4* were down-regulated, and the transcriptional alterations were also confirmed by real-time PCR. Transcriptional expression of *CHI3L1* is regulated by *TNF* or *IL1B* and *CHI3L1*, which are involved in macrophage differentiation (Recklies et al. [@CR24]; Rehli et al. [@CR25]). *CHI3L1* may play an important role in the early immune response in both monkeys and rats after exposure to welding fumes. Cathepsin K (*CTSK*), which is expressed in breast cancers, is also involved in the dendritic cell or macrophage signaling pathway and is also associated with differentiation in a leukemia cell line (Takeshita and Ishii [@CR32]; Hattori et al. [@CR11]). Additionally, cathepsin B (*CTSB*), which was up-regulated during welding fume exposure, is associated with apoptosis and proliferation in various cell lines, including lung cancer and fibroblast cell lines (Moubarak et al. [@CR16]; Bröker et al. [@CR7]). *GRAP*, which was down-regulated during welding fume exposure, plays a role in negatively regulating the proliferation of lymphocyte interleukin-2 induction (Shen et al. [@CR30]). *CYP1B1* and *CYP26B1* were highly down-regulated during welding fume exposure.

To date, studies about xenobiotic metabolism induced by welding fume exposure are limited, and the mechanisms are poorly understood. However, we found that *CYP1B1* and *CYP26B1* were deregulated in the lung after welding fume exposure. In contrast, *ID4*, a transcriptional regulator and inhibitor of DNA binding, was down-regulated during welding fume exposure. *ID4* plays an important role in the differentiation and proliferation of neural cell and epithelial cell lines (Shan et al. [@CR29]; Yun et al. [@CR40]), but its involvement in lung injury and lung inflammation has not been reported.

In a previous study, genes related to the immune response, such as *Mmp12* and *Trem2*, and many cytokines, such as *Cd5l*, *Ccl7*, and *Cxcl5*, were highly expressed in rats after welding fume exposure (Oh et al. [@CR20]). In the present study, *MMP12* was not differentially expressed in monkey lung, but *MMP9* was up-regulated, while its expression was not altered in rats. *TREM2* was consistently up-regulated in both monkeys and rats, but *TREM2* was excluded from the gene list, because its gene symbol did not match during the analysis. A previous study showed that *MMP12* was sensitively and significantly up-regulated by welding fume exposure. This difference in gene expression might be due to the degree of lung injury induced by welding fumes or to interspecies variability. This result also suggests that *TREM2* plays an important role in lung injury induced by welding fume exposure in both monkeys and rats. In the case of cytokine genes, *CD5L*, *CCL7*, and *CXCL5* were up-regulated over 1.3-fold or 2-fold in the recovery group but not in the exposure group, although *P*-value was not over 0.01. Gene expression changes of these cytokines also indicate that lung injury was chronically progressed even through recovery period.

Using microarray analysis, we demonstrated, for the first time, a comprehensive gene expression profile in monkeys after welding fume exposure and recovery. We identified several genes commonly deregulated that are involved in inflammatory response and proliferation in both monkeys and rats after welding fume exposure. This information could aid in understanding the mechanisms in lung tissues after welding fume exposure.
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